Changes to NYRx Drug Formulary Effective August 1, 2024
Click to Enlarge
The New York State Medicaid Program has implemented significant updates to the NYRx Preferred Drug List (PDL) effective August 1, 2024, following the May 16, 2024, DUR Board meeting. These changes include new additions and removals in the BLTG Program, impacting medications such as Austedo XR and liraglutide. Physicians should familiarize themselves with these updates to ensure compliance and optimize patient care. For a detailed breakdown of the changes and how they might affect your practice, please click here to read the full update.
